These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 10465074)

  • 1. Sampling lymphoid tissue cells by ultrasound-guided fine needle aspiration of lymph nodes in HIV-infected patients. Swiss HIV Cohort Study.
    Bart PA; Meuwly JY; Corpataux JM; Yerly S; Rizzardi P; Fleury S; Munoz M; Knabenhans C; Welbon C; Pantaleo G; Meylan PR
    AIDS; 1999 Aug; 13(12):1503-9. PubMed ID: 10465074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parallel decline of CD8+/CD38++ T cells and viraemia in response to quadruple highly active antiretroviral therapy in primary HIV infection.
    Tilling R; Kinloch S; Goh LE; Cooper D; Perrin L; Lampe F; Zaunders J; Hoen B; Tsoukas C; Andersson J; Janossy G;
    AIDS; 2002 Mar; 16(4):589-96. PubMed ID: 11873002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological and virological responses in HIV-1-infected adults at early stage of established infection treated with highly active antiretroviral therapy.
    Bart PA; Rizzardi GP; Tambussi G; Chave JP; Chapuis AG; Graziosi C; Corpataux JM; Halkic N; Meuwly JY; Munoz M; Meylan P; Spreen W; McDade H; Yerly S; Perrin L; Lazzarin A; Pantaleo G
    AIDS; 2000 Sep; 14(13):1887-97. PubMed ID: 10997391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Viral load and immunophenotype of cells obtained from lymph nodes by fine needle aspiration as compared with peripheral blood cells in HIV-infected patients.
    Meylan PR; Bürgisser P; Weyrich-Suter C; Spertini F
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Sep; 13(1):39-47. PubMed ID: 8797685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Limited CD4+ T-cell renewal in early HIV-1 infection: effect of highly active antiretroviral therapy.
    Fleury S; de Boer RJ; Rizzardi GP; Wolthers KC; Otto SA; Welbon CC; Graziosi C; Knabenhans C; Soudeyns H; Bart PA; Gallant S; Corpataux JM; Gillet M; Meylan P; Schnyder P; Meuwly JY; Spreen W; Glauser MP; Miedema F; Pantaleo G
    Nat Med; 1998 Jul; 4(7):794-801. PubMed ID: 9662370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Virological and immunological responses to HAART in asymptomatic therapy-naive HIV-1-infected subjects according to CD4 cell count.
    Rizzardi GP; Tambussi G; Bart PA; Chapuis AG; Lazzarin A; Pantaleo G
    AIDS; 2000 Oct; 14(15):2257-63. PubMed ID: 11089613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term kinetics of T cell production in HIV-infected subjects treated with highly active antiretroviral therapy.
    Fleury S; Rizzardi GP; Chapuis A; Tambussi G; Knabenhans C; Simeoni E; Meuwly JY; Corpataux JM; Lazzarin A; Miedema F; Pantaleo G
    Proc Natl Acad Sci U S A; 2000 May; 97(10):5393-8. PubMed ID: 10805798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphocytes proliferate in blood and lymph nodes following interleukin-2 therapy in addition to highly active antiretroviral therapy.
    Hengge UR; Borchard C; Esser S; Schröder M; Mirmohammadsadegh A; Goos M
    AIDS; 2002 Jan; 16(2):151-60. PubMed ID: 11807298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular restoration in HIV infected persons treated with abacavir and a protease inhibitor: age inversely predicts naive CD4 cell count increase.
    Lederman MM; McKinnis R; Kelleher D; Cutrell A; Mellors J; Neisler M; Cooney E; Haas DW; Haubrich R; Stanford J; Horton J; Landay A; Spreen W
    AIDS; 2000 Dec; 14(17):2635-42. PubMed ID: 11125881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamics of viral load rebound and immunological changes after stopping effective antiretroviral therapy.
    García F; Plana M; Vidal C; Cruceta A; O'Brien WA; Pantaleo G; Pumarola T; Gallart T; Miró JM; Gatell JM
    AIDS; 1999 Jul; 13(11):F79-86. PubMed ID: 10449278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Normalization of CD4+ cell numbers and reduced levels of memory CD8+ cells in blood and tonsillar tissue after highly active antiretroviral therapy in early HIV type-1 infection.
    Dyrhol-Riise AM; Voltersvik P; Røsok BI; Olofsson J; Asjö B
    AIDS Res Hum Retroviruses; 2000 Feb; 16(3):191-201. PubMed ID: 10710207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in CD4+ and CD8+ T cell subsets in response to highly active antiretroviral therapy in HIV type 1-infected patients with prior protease inhibitor experience.
    Gray CM; Schapiro JM; Winters MA; Merigan TC
    AIDS Res Hum Retroviruses; 1998 May; 14(7):561-9. PubMed ID: 9591710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting the duration of antiviral treatment needed to suppress plasma HIV-1 RNA.
    Rizzardi GP; De Boer RJ; Hoover S; Tambussi G; Chapuis A; Halkic N; Bart PA; Miller V; Staszewski S; Notermans DW; Perrin L; Fox CH; Lange JM; Lazzarin A; Pantaleo G
    J Clin Invest; 2000 Mar; 105(6):777-82. PubMed ID: 10727446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protease inhibitor-containing regimens compared with nucleoside analogues alone in the suppression of persistent HIV-1 replication in lymphoid tissue.
    Ruiz L; van Lunzen J; Arno A; Stellbrink HJ; Schneider C; Rull M; Castellà E; Ojanguren I; Richman DD; Clotet B; Tenner-Racz K; Racz P
    AIDS; 1999 Jan; 13(1):F1-8. PubMed ID: 10207538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological benefits of antiretroviral therapy in very early stages of asymptomatic chronic HIV-1 infection.
    Plana M; García F; Gallart T; Tortajada C; Soriano A; Palou E; Maleno MJ; Barceló JJ; Vidal C; Cruceta A; Miró JM; Gatell JM
    AIDS; 2000 Sep; 14(13):1921-33. PubMed ID: 10997396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease.
    Autran B; Carcelain G; Li TS; Blanc C; Mathez D; Tubiana R; Katlama C; Debré P; Leibowitch J
    Science; 1997 Jul; 277(5322):112-6. PubMed ID: 9204894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Highly active antiretroviral therapy results in HIV type 1 suppression in lymph nodes, increased pools of naive T cells, decreased pools of activated T cells, and diminished frequencies of peripheral activated HIV type 1-specific CD8+ T cells.
    Gray CM; Lawrence J; Ranheim EA; Vierra M; Zupancic M; Winters M; Altman J; Montoya J; Zolopa A; Schapiro J; Haase AT; Merigan TC
    AIDS Res Hum Retroviruses; 2000 Sep; 16(14):1357-69. PubMed ID: 11018855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency of cytokine-producing T cells in HIV-infected patients treated with stavudine, didanosine, and ritonavir.
    Levacher M; Bouscarat F; Landman R; Chau F; Damond F; Gaudebout C; Mathez D; Leibowitch J; Saimot AG; Sinet M
    AIDS Res Hum Retroviruses; 2000 Nov; 16(17):1869-75. PubMed ID: 11118072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in cellular activation and apoptosis in HIV-infected patients receiving protease inhibitors or nonnucleoside reverse transcriptase inhibitors.
    Benito JM; López M; Martín JC; Lozano S; Martínez P; González-Lahoz J; Soriano V
    AIDS Res Hum Retroviruses; 2002 Dec; 18(18):1379-88. PubMed ID: 12487809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T cell changes after combined nucleoside analogue therapy in HIV primary infection.
    Carcelain G; Blanc C; Leibowitch J; Mariot P; Mathez D; Schneider V; Saimot AG; Damond F; Simon F; Debré P; Autran B; Girard PM
    AIDS; 1999 Jun; 13(9):1077-81. PubMed ID: 10397538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.